109 related articles for article (PubMed ID: 2311848)
1. [Endoscopic detection of dysplasia and subclinical cancer of the esophagus. Results of a prospective study using toluidine blue vital staining in 100 patients with alcoholism and smoking].
Seitz JF; Monges G; Navarro P; Giovannini M; Gauthier A
Gastroenterol Clin Biol; 1990; 14(1):15-21. PubMed ID: 2311848
[TBL] [Abstract][Full Text] [Related]
2. [Incidence of esophageal cancer synchronous with upper aerodigestive tract cancers (100 cases): value of vital staining with lugol and toluidine blue].
Papazian A; Descombes P; Capron JP; Lorriaux A
Gastroenterol Clin Biol; 1985 Jan; 9(1):16-22. PubMed ID: 3979722
[TBL] [Abstract][Full Text] [Related]
3. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
[TBL] [Abstract][Full Text] [Related]
4. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
5. [Chromoendoscopy in the diagnosis of precancerous lesions of the esophagus. Our experience].
Cristofaro MG; Cafaro D; Lazzaro F; Onofrio L; Savino N; Macchione B; Mauro P; Musella S
Ann Ital Chir; 2001; 72(4):405-9; discussion 409-11. PubMed ID: 11865692
[TBL] [Abstract][Full Text] [Related]
6. Dysplasia in the human esophagus: clinicopathological study on 500 esophagi at autopsy.
Takiyama W; Moriwaki S; Mandai K; Takashima S
Jpn J Clin Oncol; 1992 Aug; 22(4):250-5. PubMed ID: 1434025
[TBL] [Abstract][Full Text] [Related]
7. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer.
Wang LD; Zhou Q; Feng CW; Liu B; Qi YJ; Zhang YR; Gao SS; Fan ZM; Zhou Y; Yang CS; Wei JP; Zheng S
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():159-72. PubMed ID: 11890101
[TBL] [Abstract][Full Text] [Related]
8. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
9. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
[TBL] [Abstract][Full Text] [Related]
10. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
11. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic screening for early esophageal cancer by iodine staining in patients with other current or prior primary cancers.
Shimizu Y; Tukagoshi H; Fujita M; Hosokawa M; Kato M; Asaka M
Gastrointest Endosc; 2001 Jan; 53(1):1-5. PubMed ID: 11154480
[TBL] [Abstract][Full Text] [Related]
13. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
14. Esophageal tumors--the role of esophagoscopy.
Roth A; Lang S; Kolarić K
Cancer Detect Prev; 1981; 4(1-4):351-9. PubMed ID: 7349797
[TBL] [Abstract][Full Text] [Related]
15. Vital staining of oesophagus in patients with head and neck cancer: still a worthwhile procedure.
Contini S; Consigli GF; Di Lecce F; Chiapasco M; Ferri T; Orsi P
Ital J Gastroenterol; 1991 Jan; 23(1):5-8. PubMed ID: 1720988
[TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
17. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].
Burdiles P; Csendes A; Smok G; Braghetto I; Korn O
Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: the role of laparoscopic fundoplication.
Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
[TBL] [Abstract][Full Text] [Related]
19. Narrow-band imaging in the diagnosis of early esophageal cancer and precancerous lesions.
Huang LY; Cui J; Wu CR; Liu YX; Xu N
Chin Med J (Engl); 2009 Apr; 122(7):776-80. PubMed ID: 19493388
[TBL] [Abstract][Full Text] [Related]
20. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
